<DOC>
	<DOCNO>NCT02771145</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy FID 120947A soft contact lens wearer Japanese ethnicity . This study conduct Japan .</brief_summary>
	<brief_title>Clinical Evaluation Safety Efficacy FID 120947A</brief_title>
	<detailed_description />
	<mesh_term>Refractive Errors</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Successful history silicone hydrogel soft contact lens wear ( except daily disposable lens ) eye past 3 month history least 5 consecutive day successful DAILY wear eye Visit 1 ; Best spectacle correct distance visual acuity great equal 0.8 ( decimal visual acuity ) eye ; Other protocolspecified inclusion criterion may apply . Any ocular systemic medical condition may , opinion Investigator , preclude safe administration investigational product affect result study ; Need wear contact lens extend wear basis ( ie , overnight ) study ; Monocular ( 1 eye functional vision ) fit 1 lens ; Use daily cleaner and/or enzyme clean care lenses least 7 day prior Visit 1 ( use lens rewetting drop acceptable ) ; History intolerance hypersensitivity component investigational product ; Unwilling unable abstain use overthecounter ( OTC ) prescribe topical ocular medication ( except rewetting drop ) within 7 day prior Visit 1 duration study ; Moderate ( grade 3 ) severe ( grade 4 ) corneal edema , corneal staining , injection ( limbal hyperemia , bulbar conjunctival hyperemia ) , tarsal abnormality , `` '' finding ; Corneal vascularization mild ( grade 2 ) high ; Conjunctival structural lid abnormality abnormal corneal opacity Visit 1 ; Current history ocular infection , severe inflammation disease within 6 month prior Visit 1 ; Any systemic disease ( include allergy , respiratory infection cold ) may affect eye exacerbate use contact lenses contact lens solution ; Use systemic medication may contribute adverse ocular effect unless stable dose regimen minimum 30 day prior Visit 1 ; Ocular intraocular surgery and/or ocular trauma within last 12 month ( exclude placement punctal plug ) ; Participation investigational clinical study within 30 day Visit 1 ; Other protocolspecified exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>